Marcaine Post-Operative Pain Study

State University of New York - Upstate Medical University

Status and phase: Completed; Early Phase 1

Conditions: Effect of Drug

Treatments: Drug: Bupivacaine Injection

Study type: Interventional

Funder types: Other

Identifiers

NCT04494880

1618426-3

Details and patient eligibility

About

The study examines the efficacy of Marcaine in post-operative pain reduction for patients receiving breast reduction surgery. Patients who consent will be randomized to which breast receives a Marcaine injection and the other breast will have saline injected. Pain will be assessed one time post-operatively using a 1-10 pain scale.

Enrollment: 22 patients

Sex: All

Ages: Under 89 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Must be receiving bilateral breast reduction surgery

Exclusion criteria

• Unilateral breast reduction surgery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

22 participants in 2 patient groups

Treatment Group (Marcaine 1 Breast)

Experimental group

Description:

Marcaine will be injected into one randomized breast and saline into the other in the treatment group.

Treatment:

Drug: Bupivacaine Injection

Control Group (Marcaine 2 Breasts)

No Intervention group

Description:

Marcaine will be injected into both breasts as is currently the standard of care.